Tg Therapeutics (TGTX) Revenue (QoQ) (2017 - 2026)
Tg Therapeutics (TGTX) Revenue (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Tg Therapeutics | 8.07 Bn | 8.00 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41% |
| Dec 31, 2025 | 19.09% |
| Sep 30, 2025 | 14.57% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 11.71% |
| Dec 31, 2024 | 28.98% |
| Sep 30, 2024 | 14.17% |
| Jun 30, 2024 | 15.74% |
| Mar 31, 2024 | 44.35% |
| Dec 31, 2023 | -73.48% |
| Sep 30, 2023 | 931.57% |
| Jun 30, 2023 | 106.00% |
| Mar 31, 2023 | 9,653.75% |
| Dec 31, 2022 | -14.89% |
| Sep 30, 2022 | -84.18% |
| Jun 30, 2022 | -70.54% |
| Mar 31, 2022 | -13.14% |
| Dec 31, 2021 | 14.33% |
| Sep 30, 2021 | 31.39% |
| Jun 30, 2021 | 94.83% |